Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Official: R/S didn't recv enough votes. https://ih.advfn.com/stock-market/USOTC/owc-pharmaceutical-research-OWCP/stock-news/79643754/current-report-filing-8-k
I spoke to my broker at TD Ameritrade and confirmed that as long as the MM's are at the same price, this can be done. I asked because I see the pattern with OTCX and watch as folks throws shares at OTCX that would be better served knocking off the other lesser MM's, allowing OTCX to retreat.
Did you know you can call your broker and ask them to target a specific Market Maker? An example being to target NITE at .0310. OTCX just absorbs shares so if you target NITE, it'll go away and OTCX will eventually retreat. Naturally this should be done when they occupy the same price.
Weird... there is a double post, though I only posted once.
To be transparent, I'm in for 4,000,000 shares at a .0009 average. I've mentioned this before because it's true, but while this stock is a risk and could fold, a $200k buy out of .0002 on the ASK would propel this symbol back up again. That's a lot of money for most of us, but to some it's a drop in the bucket. At any time of any day this could run back to where it was months ago, touching .0030. The amount of money to be made on a run like that (1,500-3,000% UP) would be staggering for the buyers.
A pattern: Do not buy at the ASK when OTCX is alone. He nearly always (if not immediately) will raise his price to the next highest ASK or near it. We need to knock out the sellers that match or go lower than OTCX. THIS WILL raise the PPS. It happens everyday, but not enough recognize this.
Example: The ASK is at .0318 for both OTCX and CDEL. Target CDEL's 50,888 and OTCX will retreat in short order.
This is what happened the other day when it ran up to .0490.
One notable difference is that CFGN is on the ASK at .0335... that is unusual, so I can't be sure how many shares they have. Could be an issue. They could fall off if shares are filling at .0335, though. Hard to say.
Talking long term PPS based on their products in the pipeline. If things go their way, I'd like to get a feel for what our posters believe the PPS upside is. Actually my $5 PPS guess is WAY off... it'd be substantially higher. I forgot this has been as high as $3 just last year.
The long-term upside is $5 PPS, if not FAR more. Anyone else have an estimate (best case)?
I love the potential of CNBX and this is a great buy in opportunity for those looking to get in. It needs to be monitored, but what they're working on is potentially game-changing.
Solid post as usual, Gary. I'm of the opinion that this week could be pivotal in the PPS moving forward. They are any number of potential scenarios, ranging from this dropping under .03 to rising to .20 (or more.) One thing I firmly believe is that at any time OTCX can step away from the ASK and the PPS can shoot way up. There are many shareholders awaiting a run back to 'at least' .16 and will not be selling, so the path for a run up to .16+ is mostly cleared. Of course, the PPS could stay stagnant, but I feel it'll move from this current .03-.04 range.
Long term, many folks -like me- feel the stock will be in the dollars again, and getting tens of thousands of shares at these prices feels like a potential windfall. There's risk, like the vast majority of stocks, but there are so many positives in the pipeline, and I think the science and management team will make us BIG winners in the end.
If OTCX would just take a break for a day or two, this would rocket way up. #Truth
$200,000 buys out the Ask at .0002. That's a lot of money for most of us, but not all. This CAN run very quickly if anyone were so inclined.
If this breaks thru @.0860, look out.
This time the past 2 yrs PURA has run WAY up. Look at the chart.
It wouldn't shock me too see .16 today. Surprised? Sure, but with a potential MM patent looming, insiders may run with it and make a killing. I get it's not a likely scenario, as things aren't clear, but this is worth far more than its current PPS and a huge run can happen at any time.
Time will tell... it always does.
Hoping this news will push us over .04 today. =)
Nice bounce up coming. Ask is weak up to .09+
Speculation of a buyout is always in the back of my mind. That's why it's important to me to always have shares. PURA is not the best run company in regards to communication with investors, but they seem to be building a company that should be VERY rewarding for shareholders. That can happen in a heartbeat. One moment it's at .08 and the next it's at $1.00 PPS.
In my view, it's a matter of time.
A buyout/acquisition, especially for a strong-science based company, is always a possibility. These things can happen in a heartbeat, and those without shares will be paying a serious premium to jump in.
Smart play.
Great news. This WILL pay off. The science is too good.
This new collaboration is outstanding news. Further confirmation of OWCP's commitment to being one of the premiere players in medical-based cannabis research and development.
OWCP to Collaborate with Sourasky Medical Center https://www.businesswire.com/news/home/20190327005514/en/
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on Its Cannabis-Based Tablets
Tel Aviv Sourasky Medical Center will conduct a safety and tolerability trial on OWC’s sublingual tablets for the treatment of chronic low back pain
RAMAT GAN, Israel--(BUSINESS WIRE)-- OWC Pharmaceutical Research Corp.(OWCP) (owcpharma.com/), the company transforming cannabis into scientifically proven and clinically approved medical solutions, announces an agreement with the Tel Aviv Sourasky Medical Center Fund.
The medical center will perform a single-dose, randomized crossover study to compare the safety, tolerability, and pharmacokinetics of OWC’s tablet with Buccal Sativex in healthy adult volunteers. The tablet is designed to provide rapid API uptake through buccal membranes and to be a substitute for patients being treated with medical cannabis by smoking.
OWC Pharmaceutical Research Corp. (OWCP) is focusing its efforts on developing cannabis-based therapeutic products and treatments, specifically designed for several medical conditions and diseases. The company’s solutions include a topical ointment to treat skin diseases, such as psoriasis, a sublingual disintegrating tablet to treat chronic pain, and a unique formulation aimed at treating multiple Myeloma, a cancer of the plasma cells found in bone marrow.
“There is a very large amount of hype surrounding medical applications of cannabis, but we are one of the few companies doing real medical research,” says Mordechai Bignitz, CEO of OWC Pharmaceutical Research Corp.(OWCP) “Our collaboration with Sourasky Medical Center is further proof of our commitment to developing real cannabis-based medical solutions.”
Hasn't been all morning. Theoretically, the opportunity for OWCP to run is here, now. Just needs volume and once the .03xx asks break, it could shoot way up.
OTCX could take a hiatus for awhile, surprising us all. It would allow the PPS to go up significantly, and his/their re-appearance could sell at a far higher price.
I'm confident that OWCP will be well worth the long-term investment. There are a multitude of reasons that this will run WAY up to where it was before ($3 PPS), or notably higher. The pay-off should be remarkable.
It's funny, but the OTCX seller has plenty of room to retreat to the next ASK level, and often does, but has not done that as yet today. We could be back up and over .04 at any moment.
The push to .0120+ could occur by the close. The Ask is weak to .0125, and may get to .0130+ by Friday. Like I've said, this could, again 'could' run back up to well over the .0140 area to as high as .03
This has hit .03 four times in the recent four month period. It WILL run very soon.
Great post Milo. I appreciate your time and efforts to share your insight and experiences with us. I'm VERY excited to be a 'long' and just want to thank you, again.
We should see .0120-.0130+ very shortly (today or by Friday). This looks VERY strong moving forward, with the safety trial in Phase Two and the partnership with PURA.
If .0850 breaks on the Ask, this could run into the .09's.
A LOT of room above .085 on the ASK.
With a buyout, what would the PPS be? I understand it's just speculation, but I'd be curious to get an idea.
One scenario: A run back up to .20-.25 through March/April with a RS for 25-1 potentially awaiting. That would make sense, pending approval, naturally. One major factor is that the company has said 'up to 500-1', which in my view was done to protect themselves in case the symbol dropped unexpected to trips. At this juncture, OWCP has many positives that longs can feel very good about.
New Safety Study of Tablets! http://archive.fast-edgar.com/20190314/AV24L22CZ22RB2P3222V2WX2STP9ZZ22Z2B2
OWC Pharmaceutical Research Corp. (“OWC”) is happy to announce the execution of a contract with the Souraski Medical Center Fund in Tel Aviv for performing a Single-Dose, Randomized, Crossover Study to compare the Safety, Tolerability and Pharmacokinetics of OWC’s Medical Grade Cannabis - Orally Disintegrating Tablets (MGC-ODT) with Buccal Sativex®, in Healthy Adult Volunteers. This Clinical Trial Agreement (the “Agreement”) is between One World Cannabis Ltd., a company organized and existing under the laws of Israel and a wholly-owned subsidiary of OWC, and The Medical, Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Israel, and Prof. Jacob Ablin M.D. as the Principal Investigator. The primary objectives of the study are:
1. To investigate the pharmacokinetics profile of THC, 11-OH THC and CBD following a single sublingual dose of MGC-ODT.
2. To compare the pharmacokinetic profiles of THC, THC metabolite 11-hydroxy-THC and CBD following a single administration of the investigational MGC-ODT vs. Sativex® Oromucosal Spray.
3. To monitor and compare the safety and tolerability of the MGC-ODT and Sativex® in the participating subjects.
True, OWCP can go up 5,000%-7,000% from here and it's easy to forget that sometimes. How long it takes will be discovered soon enough. :) Great post.
Outstanding post Gary, thank you. Go OWCP!
Thank you kindly Stockfan & TSand for the replies. Moving forward the ROTH inclusion may be incredibly HUGE news for OWCP. I suspect tomorrow (3-14) will be telling.